Of mice and men: The function of plasminogen activator inhibitors (PAIs) in vivo

Advances in Experimental Medicine and Biology

Volumn 425, Issue , 1997, Pages 131-141

  Eitzman, Daniel T ^a   Ginsburg, David ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; HYDROXYPROLINE; NEOMYCIN; PHOSPHOGLYCERATE KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE INHIBITOR; THYMIDINE KINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VITRONECTIN;

ARTICLE; BLOOD CLOTTING; CANCER INVASION; GENE CASSETTE; GENE EXPRESSION; GENE TARGETING; HUMAN; LUNG FIBROSIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEINASE INHIBITION; SEQUENCE HOMOLOGY;

ANIMALS; BLOOD COAGULATION; FIBRINOLYSIS; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PULMONARY FIBROSIS; URINARY PLASMINOGEN ACTIVATOR; VITRONECTIN;

EID: 0031442101     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (23)

1. Francis CW, Marder VJ: Physiologic regulation and pathologic disorders of fibrinolysis, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis. Basic Principles and Clinical Practice, Philadelphia, J. B. Lippincott Company, 1987, p 358
2. Loskutoff DJ, Sawdey M, Mimuro J: Type l plasminogen activator inhibitor. Prog Hemost Thromb 9:87, 1989
3. Lawrence D, Strandberg L, Grundström T, Ny T: Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells. Eur J Biochem 186:523, 1989
4. Declerck PJ, De Mol M, Alessi MC, Baudner S, Paques E-P, Preissner KT, Müller-Berghaus G, Collen D: Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein. J Biol Chem 263:15454, 1988
5. Kruithof EKO, Baker MS, Bunn CL: Biological and clinical aspects of plasminogen activator inhibitor type 2 (PAI-2). Blood 86:4007, 1995
6. Dear AE, Medcalf RL: The cellular and molecular biology of plasminogen activator inhibitor type-2. Fibrinolysis 9:321, 1995
7. 1. J Immunol 155:1304, 1995
8. Dickinson JL, Bates EJ, Ferrante A, Antalis TM: Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis. J Biol Chem 270:27894, 1995
9. Saksela O, Rifkin DB: Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93, 1988
10. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators.tissue degradation.and cancer. Adv Cancer Res 44:139, 1985
11. Schleef RR, Higgins DL, Pillemer E, Levitt LJ: Bleeding diathesis due to decreased functional activity of Type 1 plasminogen activator inhibitor. J Clin Invest 83:1747, 1989
12. Diéval J, Nguyen G, Gross S, Delobel J, Kruithof EKO: A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood 77:528, 1991
13. Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D: Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med 327:1729, 1992
14. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast GC, Cole MD, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 gene-deficient mice. 1. Generation by homologous recombination and characterization. J Clin Invest 92:2746, 1993
15. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D: Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92:2756, 1993
16. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen JL, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419, 1994
17. Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D: Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 92:12426, 1995
18. Preissner KT: Structure and biological role of vitronectin. Annu Rev Cell Biol 7:275, 1991
19. Tomasini BR, Mosher DF: Vitronectin. Prog Hemost Thromb 10:269, 1991
20. Lawrence DA, Ginsburg D: Plasminogen Activator Inhibitors, in High KA, Roberts HR (eds): Molecular Basis of Thrombosis and Hemostasis, New York, Marcel Dekker, Inc. 1995, p 517
21. Vassalli J-D, Pepper MS: Membrane proteases in focus. Nature 370:14, 1994
22. Cajot JF, Kruithof EK, Schleuning WD, Sordat B, Bachmann F: Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 38:719, 1986
23. Hearing VJ, Law LW, Corti A, Appella E, Blasi F: Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res 48:1270, 1988